EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹295 Cr | ₹239 Cr | ₹268 Cr | ₹267 Cr | ₹170 Cr |
What is the latest Short Term Loans and Advances ratio of EMCURE PHARMACEUTICALS ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2025 | ₹295 Cr |
| Mar2024 | ₹239 Cr |
| Mar2023 | ₹268 Cr |
| Mar2022 | ₹267 Cr |
| Mar2021 | ₹170 Cr |
How is Short Term Loans and Advances of EMCURE PHARMACEUTICALS Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2025 | ₹295 Cr | 23.50 | |
| Mar2024 | ₹239 Cr | -10.62 | |
| Mar2023 | ₹268 Cr | 0.38 | |
| Mar2022 | ₹267 Cr | 56.85 | |
| Mar2021 | ₹170 Cr | - | |
Compare Short Term Loans and Advances of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹32,816.2 Cr | -0.9% | 3.1% | 30.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,785.0 Cr | 0.4% | -4.6% | 6.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,242.0 Cr | 0.7% | -1.1% | 2.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,058.0 Cr | 2.9% | -1.2% | 42.7% | Stock Analytics | |
| CIPLA | ₹111,180.0 Cr | -1.5% | 5.5% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,149.0 Cr | 0.4% | -0.6% | 1.3% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -0.9% |
3.1% |
30.8% |
| SENSEX | -0.5% |
-4.3% |
-8.4% |
You may also like the below Video Courses